If you look at the ACC's paper, on the first page, in the fifth line of the abstract you will read "Although SFAs increase low-density lipoprotein (LDL) cholesterol, in most individuals, this is not due to increasing levels of small, dense LDL particles, but rather larger LDL particles, which are much less strongly related to CVD risk. " So a clear recognition of an increase in certain LDL.
I found this in Hooper, the first of the papers you linked in support:
We found little or no effect of reducing saturated fat on all‐cause mortality (RR 0.96; 95% CI 0.90 to 1.03; 11 trials, 55,858 participants) or cardiovascular mortality (RR 0.95; 95% CI 0.80 to 1.12, 10 trials, 53,421 participants), both with GRADE moderate‐quality evidence.
I think that agrees with what the ACC paper says "...no beneficial effects of reducing SFA intake on cardiovascular disease (CVD) and total mortality"
I guess we'll just have to differ.